← FDA Drug Approvals (Drugs@FDA)

EC-NAPROSYN

NDA · New Drug Application · Sponsor: ATNAHS PHARMA US · Approved 1994-10-14

Drug application

FDA Application #
NDA020067
Application type
New Drug Application
Brand name
EC-NAPROSYN
Generic name
NAPROXEN
Active ingredients
NAPROXEN
Dosage form
TABLET, DELAYED RELEASE
Route
ORAL
Marketing status
Prescription
Sponsor
ATNAHS PHARMA US
Manufacturer
Zameer Pharmaceuticals LLC
First approval
1994-10-14

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown